Cargando…
Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells
INTRODUCTION: Bisphosphonates have become standard therapy for the treatment of skeletal complications related to breast cancer. Although their therapeutic effects mainly result from an inhibition of osteoclastic bone resorption, in vitro data indicate that they also act directly on breast cancer ce...
Autores principales: | Journé, Fabrice, Kheddoumi, Naïma, Chaboteaux, Carole, Duvillier, Hugues, Laurent, Guy, Body, Jean-Jacques |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374955/ https://www.ncbi.nlm.nih.gov/pubmed/18190680 http://dx.doi.org/10.1186/bcr1845 |
Ejemplares similares
-
Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines
por: Journe, Fabrice, et al.
Publicado: (2006) -
Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells
por: Journe, F, et al.
Publicado: (2004) -
Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival
por: Fromigue, O, et al.
Publicado: (2003) -
Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis
por: Berehab, Mimoune, et al.
Publicado: (2021) -
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
por: Rothé, Françoise, et al.
Publicado: (2011)